Additionally, in breast cancer, MAP7 upregulation is associated with paclitaxel resistance, while its downregulation inhibits cell viability, motility, and invasion, and enhances apoptosis in paclitaxel-resistant cells [18]. Here, MAP7 is linked to breast cancer.